July 5th, 2017
Two young scientists working in South Africa, both of whom were participants in the Novartis and University of Basel Next Generation Scientist programme, have been...
A European Medicines Agency (EMA) panel has recommended approving Novartis's Kisqali drug, bolstering the Swiss drugmaker's bid to challenge rival Pfizer's Ibrance...International
Greece's justice minister said Swiss pharmaceutical giant Novartis had likely bribed 'thousands' of doctors and civil servants to promote its products, amid an ongoing...International
A new leukaemia treatment from Novartis for children and young adults will get priority review from the US Food and Drug Administration (FDA), putting the Swiss...
February 15th, 2017The successful expansion of services for HIV/Aids, TB and malaria has highlighted the inadequacy of existing services to deliver interventions for other health needs,...
South Africa’s unhealthy population makes the county attractive to pharmaceutical multinationals. Business Day reports that this is according to BMI Research, which...Pharmaceutical
The US Food and Drug Administration gave fast-track review status to Novartis's medication ribociclib in first-line treatment of postmenopausal women with advanced...
November 2nd, 2016For many years, doctors, scientists and researchers have urged that clinical drug trial data be shared to accelerate medical advances in treating multiple diseases. But...
Novartis's heart failure drug Entresto will be subjected to a battery of new trials as the drugmaker seeks to boost the medicine after a disappointing introduction,...News Update
